OV
Ovation Science Inc.
OVATF · OTC
$0.01 +0.00% (+$0.00)
Market Cap $403.4K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.01
33.3% upside
Current Price
$0.0075
Undervalued Fair Value Overvalued
According to Bulios Fair Price, OVATF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
15 /100
Expensive P/S 7.03x
PEG N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 21.11%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 1,143.60%
Op. margin 1,101.87%
FCF margin 202.89%
Quality
79 /100
Excellent ROA 2,550.69%
Asset turnover 2.23x
ROIC 42.15%
Debt
0 /100
High Int. coverage -18.70x
Current ratio 0.01x
Net debt/EBITDA N/A
Stability
39 /100
Moderate Rev. volatility 75.68%
EPS volatility 44.01%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about OVATF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Terry H. Howlett
Employees
5
Headquarters
Vancouver